AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Learn how to identify crypto coins to hold long term based on fundamentals, use cases, and risk tolerance. Build a resilient, diversified portfolio with smart criteria.
28,040 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
A veteran venture investor who backed Nvidia in 2016 reveals a third high-conviction call to lift hardware stocks, ty...
Geospace's 2026 earnings trajectory shows modest top-line growth, improving margins, and a healthy backlog. This deep...
ZoomInfo's go-to-market approach is evolving as 2026 unfolds. This analysis breaks down the GTM moves behind the earn...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
BingEx reports Q1 2026 results that reveal both momentum and headwinds. This article breaks down the key numbers, exp...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...
A pivotal moment in AI memory stocks could propel a leading name higher after Micron's earnings. This article breaks ...
As a new Fed chair, chair kevin warsh will confront two high-stakes tests in just 100 days. One test centers on polit...
A recent SEC Form 4 shows a Teladoc executive sold roughly $71,000 worth of stock. This article breaks down what that...
Netflix’s strategic shift sent a ripple through the market, highlighting how breakup fees and deal terms shape stream...